Vimarsana
Biggest News Aggregation in the World

Page 3 - Mayo Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mayo Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mayo Score Today - Breaking & Trending Today

Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis - Vimarsana News

Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis

EQS-News: ABIVAX / Key word: Study results Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis 17.04.2023 / 18:00... | April 17, 2023

Mirikizumab Approval Denied Over Issues Related to Proposed Manufacturing - Vimarsana News

Mirikizumab Approval Denied Over Issues Related to Proposed Manufacturing

The FDA has rejected the application for mirikizumab for the treatment of ulcerative colitis.

Source: empr.com
Risankizumab Improves Ulcerative Colitis Symptoms in Phase 3 Induction Study - Vimarsana News

Risankizumab Improves Ulcerative Colitis Symptoms in Phase 3 Induction Study

Treatment with risankizumab achieved clinical remission and an improvement in symptoms in adults with moderately to severely active ulcerative colitis.

Source: empr.com
Related Topics:
Mayo Score
Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis - Vimarsana News

Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis

Ritlecitinib and brepocitinib were both more effective than placebo with acceptable safety in a phase 2b study of patients with moderate to severe ulcerative colitis.

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Material Update from Portfolio Company - Vimarsana News

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Material Update from Portfolio Company

Investegate announcements from RTW Venture Fund Ltd, Material Update from Portfolio Company